Ultragenyx Pharmaceutical Inc. (RARE)

Ultragenyx Pharmaceutical Revenue

Ultragenyx Pharmaceutical had revenue of $214.00M in the quarter ending June 30, 2026, with 28.14% growth. This brings the company's total for the last twelve months to $717.21M, up 17.55% year-over-year. In the year 2025, Ultragenyx Pharmaceutical had annual revenue of $673.00M with 20.18% growth. That makes Ultragenyx Pharmaceutical the 9,283rd largest company in the world by revenue and 2,041st in the United States.

• Revenue (ttm): $717.21M
• Revenue Growth: +17.55%
• P/S Ratio: 2.21
• Revenue / Employee: $522,976
• Employees: 1,371
• Market Cap: 1.58B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Crysvita Royalty 304.00M 45.2%
• Crysvita 177.00M 26.3%
• Dojolvi 96.00M 14.3%
• Evkeeza 59.00M 8.8%
• Mepsevii 37.00M 5.5%

By Geography

Chart

• North America 377.00M 56.0%
• Latin America 170.00M 25.3%
• Europe 108.00M 16.0%
• Asia-Pacific 18.00M 2.7%

Fiscal year ended Dec 31, 2025 See the full Ultragenyx Pharmaceutical breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	673.00M	113.00M	20.18%
Dec 31, 2024	560.00M	126.00M	29.03%
Dec 31, 2023	434.00M	70.67M	19.45%
Dec 31, 2022	363.33M	11.92M	3.39%
Dec 31, 2021	351.41M	80.38M	29.66%
Dec 31, 2020	271.03M	167.32M	161.32%
Dec 31, 2019	103.71M	52.22M	101.41%
Dec 31, 2018	51.50M	48.88M	1,871.48%
Dec 31, 2017	2.61M	2.48M	1,863.91%
Dec 31, 2016	133.00K	-	-
Dec 31, 2015	-	-	-
Dec 31, 2014	-	-	-
Dec 31, 2013	-	-	-
Dec 31, 2012	-	-	-
Dec 31, 2011	-	-	-

Data Source: Fiscal.ai Last updated: Aug 4, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 28, 2026

Data Sources Report a data error